Lung cancer is a complex disease. It is not one-size-fits-all. Stage III non-small cell lung cancer (NSCLC) is a prime example. It is a mixed bag of different subgroups. Some respond well to treatment. Others do not. This is why identifying these subgroups is so important. It helps doctors tailor treatments to each patient's needs. One treatment that has show...
In the treatment of lung cancer, doctors often use a combination of chemotherapy and radiation. But there is a problem. Sometimes, this mix causes a serious side effect called pneumonitis. This is when the lungs become inflamed. Pneumonitis can be bad enough to stop treatment. But what happens if doctors try to start the treatment again? This is what researcher...
Lung cancer is a serious issue, and small-cell lung cancer (SCLC) is one of the trickier types. It often spreads quickly, making it hard to treat. Doctors have been looking for better ways to fight it. One approach is to use a mix of drugs that work together to attack the cancer from different angles. This is where carboplatin, etoposide, atezolizumab, and bevaci...
Non-small cell lung cancer often requires surgery. But, before the operation, there is a lot that can be done to help patients. One of the ways is by getting patients ready with a fast, mixed program before the surgery. This program is designed to improve how patients feel and function after their operation. This program is not about long-term changes. It is abo...
Mendelian randomization (MR) has become a hot topic in lung cancer (LC) research. This method uses genetic variations to figure out if certain factors cause disease. Yet, there hasn"t been a thorough look at how this field has grown worldwide. This is where a recent study steps in. It dives into global research trends, key players, and new themes in MR related to...
Lung cancer is a sneaky and deadly disease. It often goes unnoticed until it's too late. This is because symptoms usually only show up when the cancer has already spread. But there is a way to spot it early. Low-dose computed tomography (CT) scans can find lung cancer before it becomes a big problem. These scans use much less radiation than regular CT scans. This mak...
In China, a new treatment for lung cancer is gaining attention. Penpulimab, a type of drug known as a PD-1 monoclonal antibody, is being used alongside paclitaxel and carboplatin. This combination is showing promise for patients with a specific type of lung cancer called squamous non-small cell lung cancer (sqNSCLC). This research digs into whether this new ...
In Hungary, a stark contrast exists in lung cancer rates and survival between those experiencing homelessness and the general public. The gap in healthcare use and outcomes is significant, yet often overlooked. This issue is particularly pressing within the country's universal healthcare system. The link between homelessness and lung cancer is clear. From 2015 to 20...
Lung cancer is a serious disease. It is important to understand the choices people make when dealing with it. Non-small cell lung cancer is the most common type. So, what matters most to patients, their supporters, and doctors when they make treatment choices? There are many aspects to consider. Patients have their own priorities. They often want treatments that wi...
Lung cancer is a significant health issue, and non-small cell lung cancer (NSCLC) is a common type. One way to fight it is by targeting something called PD-L1, which is often found on lung cancer cells. Blocking PD-L1 can help the body's immune system attack the cancer. This is where aptamers come in. Aptamers are like tiny, smart molecules that can stick to specific...